H. KOC Et Al. , "Treatment of secondary hyperparathyroidism with paricalcitol in patients with end-stage renal disease undergoing hemodialysis in Turkey: an observational study," INTERNATIONAL UROLOGY AND NEPHROLOGY , vol.51, no.7, pp.1261-1270, 2019
KOC, H. Et Al. 2019. Treatment of secondary hyperparathyroidism with paricalcitol in patients with end-stage renal disease undergoing hemodialysis in Turkey: an observational study. INTERNATIONAL UROLOGY AND NEPHROLOGY , vol.51, no.7 , 1261-1270.
KOC, H., HOSER, H., AKDAĞ, Y., KENDIR, C., & Ersoy, F. F., (2019). Treatment of secondary hyperparathyroidism with paricalcitol in patients with end-stage renal disease undergoing hemodialysis in Turkey: an observational study. INTERNATIONAL UROLOGY AND NEPHROLOGY , vol.51, no.7, 1261-1270.
KOC, Hasan Et Al. "Treatment of secondary hyperparathyroidism with paricalcitol in patients with end-stage renal disease undergoing hemodialysis in Turkey: an observational study," INTERNATIONAL UROLOGY AND NEPHROLOGY , vol.51, no.7, 1261-1270, 2019
KOC, Hasan Et Al. "Treatment of secondary hyperparathyroidism with paricalcitol in patients with end-stage renal disease undergoing hemodialysis in Turkey: an observational study." INTERNATIONAL UROLOGY AND NEPHROLOGY , vol.51, no.7, pp.1261-1270, 2019
KOC, H. Et Al. (2019) . "Treatment of secondary hyperparathyroidism with paricalcitol in patients with end-stage renal disease undergoing hemodialysis in Turkey: an observational study." INTERNATIONAL UROLOGY AND NEPHROLOGY , vol.51, no.7, pp.1261-1270.
@article{article, author={Hasan KOC Et Al. }, title={Treatment of secondary hyperparathyroidism with paricalcitol in patients with end-stage renal disease undergoing hemodialysis in Turkey: an observational study}, journal={INTERNATIONAL UROLOGY AND NEPHROLOGY}, year=2019, pages={1261-1270} }